Kyongbo Pharmaceutical Co., Ltd

KOSE:A214390 株式レポート

時価総額：₩177.9b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Kyongbo Pharmaceutical マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Tae-Young Kim

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権n/a
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Kyongbo Pharmaceutical (KRX:214390) Has A Somewhat Strained Balance Sheet

Mar 09
Kyongbo Pharmaceutical (KRX:214390) Has A Somewhat Strained Balance Sheet

What Type Of Shareholders Own The Most Number of Kyongbo Pharmaceutical Co., Ltd (KRX:214390) Shares?

Feb 02
What Type Of Shareholders Own The Most Number of Kyongbo Pharmaceutical Co., Ltd (KRX:214390) Shares?

Kyongbo Pharmaceutical Co., Ltd's (KRX:214390) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Jan 12
Kyongbo Pharmaceutical Co., Ltd's (KRX:214390) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Did You Miss Kyongbo Pharmaceutical's (KRX:214390) Impressive 107% Share Price Gain?

Dec 25
Did You Miss Kyongbo Pharmaceutical's (KRX:214390) Impressive 107% Share Price Gain?

Is Kyongbo Pharmaceutical (KRX:214390) A Risky Investment?

Dec 08
Is Kyongbo Pharmaceutical (KRX:214390) A Risky Investment?

Does Kyongbo Pharmaceutical's (KRX:214390) Statutory Profit Adequately Reflect Its Underlying Profit?

Nov 18
Does Kyongbo Pharmaceutical's (KRX:214390) Statutory Profit Adequately Reflect Its Underlying Profit?

CEO（最高経営責任者

Tae-Young Kim

no data

在職期間

Tae-Young Kim is Chief Executive Officer of Kyongbo Pharmaceutical Co., Ltd.